|
W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER
|
Back to Search Results |
|
| Catalog Number |
DSF1245 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Ischemia Stroke (4418)
|
| Date of Event |
10/31/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
| |
|
Event or Problem Description
|
|
The following information was reported to gore: on (b)(6) 2025, this patient underwent an endovascular treatment for thoracoabdominal aortic aneurysm using gore® excluder® thoracoabdominal branch endoprosthesis (tambe).On the same day after the procedure, the patient showed delayed recovery from general anesthesia and subsequently developed symptoms such as fatigue and difficulty speaking.Cerebral infarction was confirmed.At the time of this reporting, rehabilitation was ongoing, and the patient¿s condition had improved; however, he was still hospitalized.The reporting physician commented as follows: since transcatheter aortic valve implantation (tavi) was performed three days prior to this procedure (on (b)(6) 2025), it is unclear whether this event was caused by the tambe procedure.However, as a gore® dryseal flex introducer sheath was inserted via the right axillary artery over the origins of the right vertebral artery and common carotid artery, and complex device manipulation was performed during the procedure, it is possible that the sheath contributed to the onset of cerebral infarction.
|
| |
|
Search Alerts/Recalls
|
|
|